Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018

Mirjam J. Knol; Wilhelmina L. M. Ruijs; Laura Antonise-Kamp; Hester E. de Melker; Arie van der Ende

doi:10.2807/1560-7917.ES.2018.23.16.18-00158

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018

Mirjam J. Knol
, Wilhelmina L. M. Ruijs
, Laura Antonise-Kamp
, Hester E. de Melker
, Arie van der Ende

Research output: Contribution to journal › Article › Academic › peer-review

5 Downloads (Pure)

Abstract

The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination.

Original language	English
Article number	18-00158
Journal	Euro surveillance
Volume	23
Issue number	16
DOIs	https://doi.org/10.2807/1560-7917.ES.2018.23.16.18-00158
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2807/1560-7917.ES.2018.23.16.18-00158

Implementation-of-menacwy-vaccination-because-of-ongoing-increase-in-serogroup-w-invasive-meningococcal-disease-the-net.pdfFinal published version, 239 KBLicence: CC BY

Cite this

@article{948780dfb3d44588926e3fc666aba8a0,

title = "Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018",

abstract = "The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94\%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12\% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination.",

author = "Knol, \{Mirjam J.\} and Ruijs, \{Wilhelmina L. M.\} and Laura Antonise-Kamp and \{de Melker\}, \{Hester E.\} and \{van der Ende\}, Arie",

year = "2018",

doi = "10.2807/1560-7917.ES.2018.23.16.18-00158",

language = "English",

volume = "23",

journal = "Euro surveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "16",

}

TY - JOUR

T1 - Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018

AU - Knol, Mirjam J.

AU - Ruijs, Wilhelmina L. M.

AU - Antonise-Kamp, Laura

AU - de Melker, Hester E.

AU - van der Ende, Arie

PY - 2018

Y1 - 2018

N2 - The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination.

AB - The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination.

UR - https://www.scopus.com/pages/publications/85045879597

UR - https://www.ncbi.nlm.nih.gov/pubmed/29692317

U2 - 10.2807/1560-7917.ES.2018.23.16.18-00158

DO - 10.2807/1560-7917.ES.2018.23.16.18-00158

M3 - Article

C2 - 29692317

SN - 1025-496X

VL - 23

JO - Euro surveillance

JF - Euro surveillance

IS - 16

M1 - 18-00158

ER -

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this